Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142563 |
| CAS No | NA |
| Mol.F. | C15H22N2O3 |
| Mol.Wt. | 278.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142564 |
| CAS No | NA |
| Mol.F. | C18H28N2O6 |
| Mol.Wt. | 368.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142565 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142566 |
| CAS No | NA |
| Mol.F. | C19H23N3O3 |
| Mol.Wt. | 341.4g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142567 |
| CAS No | NA |
| Mol.F. | C14H11N3O2 |
| Mol.Wt. | 253.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142568 |
| CAS No | 862542-34-5 |
| Mol.F. | C8H13N3O7 |
| Mol.Wt. | 263.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142569 |
| CAS No | NA |
| Mol.F. | C19H18N2O |
| Mol.Wt. | 290.37 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142570 |
| CAS No | NA |
| Mol.F. | C22H24N2O |
| Mol.Wt. | 332.45 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142571 |
| CAS No | NA |
| Mol.F. | C22H21F3N2O |
| Mol.Wt. | 386.42 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142572 |
| CAS No | NA |
| Mol.F. | C21H23F3N2O2 |
| Mol.Wt. | 392.42 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142573 |
| CAS No | NA |
| Mol.F. | C22H25F3N2O |
| Mol.Wt. | 390.45 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142574 |
| CAS No | NA |
| Mol.F. | C22H21F3N2O |
| Mol.Wt. | 386.45 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142575 |
| CAS No | NA |
| Mol.F. | C22H27F3N2O |
| Mol.Wt. | 392.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142576 |
| CAS No | NA |
| Mol.F. | C18H30N2O5 |
| Mol.Wt. | 354.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142577 |
| CAS No | NA |
| Mol.F. | C25H37N3O5 |
| Mol.Wt. | 459.59 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142578 |
| CAS No | NA |
| Mol.F. | C26H39N306 |
| Mol.Wt. | 489.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |